
  
    
      
        Background_NNP
        The_DT proto-oncogene_JJ TEL_NNP (_( Translocation_NNP ,_, Ets_NNP ,_, Leukemia_NNP )_) is_VBZ
        a_DT transcriptional_NN repressor_NN that_WDT contains_VBZ a_DT C-_NNP terminal_NN Ets_NNP
        family_NN DNA_NNP binding_JJ domain_NN ;_: a_DT central_JJ domain_NN that_IN together_RB
        with_IN co-repressors_JJ recruit_NN histone_NN deacetylases_NNS [_NN 1_CD 2_CD 3_CD ]_NN ;_:
        and_CC an_DT N-_NNP terminal_NN SAM_NNP (_( sterile_JJ ,_, alpha_NN ,_, motif_NN )_) domain_NN [_NN 4_CD 5_CD
        6_CD ]_NN ,_, which_WDT we_PRP have_VBP recently_RB shown_VBN forms_VBZ a_DT polymer_NN [_NN 7_CD ]_NN ._.
        Chromosomal_NNP translocations_NNS in_IN a_DT variety_NN of_IN leukemias_NNS result_VBP
        in_IN fusion_NN of_IN the_DT SAM_NNP domain_NN of_IN TEL_NNP to_TO tyrosine_NN kinase_NN
        domains_NNS such_JJ as_IN ABL_NNP ,_, PDGFβ_NNP and_CC JAK_NNP 2_CD [_NN 8_CD 9_CD 10_CD 11_CD 12_CD 13_CD 14_CD ]_NN
        or_CC to_TO the_DT transcriptional_NN activators_NNS AML_NNP 1_CD and_CC ARNT_NNP [_NN 15_CD 16_CD
        17_CD ]_NN ._. In_IN the_DT tyrosine_NN kinase_NN fusions_NNS ,_, SAM_NNP domain_NN
        polymerization_NN leads_VBZ to_TO constitutive_JJ activation_NN of_IN the_DT
        tyrosine_NN kinase_NN domains_NNS ,_, which_WDT leads_VBZ in_IN turn_RB to_TO cell_NN
        transformation_NN [_NN 10_CD 12_CD 18_CD 19_CD ]_NN ._. Thus_RB ,_, compounds_NNS that_WDT block_VBP
        TEL-SAM_NNP polymerization_NN could_MD be_VB effective_JJ in_IN treating_VBG these_DT
        leukemias_NNS ._. To_TO assess_VB the_DT feasibility_NN of_IN this_DT approach_NN it_PRP
        would_MD be_VB useful_JJ to_TO have_VB a_DT structure_NN of_IN the_DT polymer_NN ._.
        The_DT wild-type_JJ TEL-SAM_NNP polymer_NN forms_NNS large_JJ insoluble_JJ
        aggregates_NNS ,_, which_WDT precludes_VBZ structure_NN determination_NN ._. We_PRP
        were_VBD ,_, however_RB ,_, able_JJ to_TO obtain_VB a_DT structure_NN of_IN a_DT mutant_JJ
        TEL-SAM_NNP polymer_NN ,_, V_NNP 80_CD E_NNP [_NN 7_CD ]_NN ._. The_DT V_NNP 80_CD E_NNP mutation_NN is_VBZ in_IN the_DT
        center_NN of_IN the_DT polymer_NN interface_NN and_CC reduces_VBZ the_DT affinity_NN of_IN
        subunit_NN association_NN enough_RB that_IN the_DT protein_NN is_VBZ relatively_RB
        soluble_JJ above_IN pH_NN 7_CD ._. 0_CD ,_, where_WRB the_DT Glu_NNP side_NN chain_NN is_VBZ
        deprotonated_JJ ._. Sufficient_NNP affinity_NN remains_VBZ ,_, however_RB ,_, that_IN
        upon_IN crystallization_NN ,_, the_DT polymer_NN reforms_NNS in_IN the_DT crystal_NN ._.
        The_DT structure_NN of_IN the_DT V_NNP 80_CD E_NNP mutant_JJ TEL-SAM_NNP revealed_VBD a_DT helical_JJ
        head-to-tail_JJ polymer_NN in_IN which_WDT the_DT interface_NN is_VBZ made_VBN from_IN
        two_CD different_JJ surfaces_VBZ on_IN the_DT protein_NN ._. One_CD binding_JJ surface_NN ,_,
        the_DT mid-loop_JJ (_( ML_NNP )_) surface_NN ,_, consists_VBZ of_IN residues_NNS near_IN the_DT
        middle_NN of_IN the_DT protein_NN and_CC the_DT second_JJ surface_NN ,_, the_DT end-helix_JJ
        (_( EH_NNP )_) surface_NN ,_, is_VBZ centered_VBN around_IN the_DT C-_NNP terminal_NN helix_NN ._.
        Although_IN the_DT V_NNP 80_CD E_NNP mutant_JJ self-associates_JJ weakly_RB under_IN the_DT
        high_JJ pH_NN conditions_NNS used_VBN for_IN crystallization_NN ,_, we_PRP were_VBD able_JJ
        to_TO show_VB that_IN the_DT native_JJ interface_NN is_VBZ quite_RB strong_JJ ._. In_IN
        particular_JJ ,_, a_DT protein_NN with_IN a_DT mutation_NN in_IN the_DT EH_NNP surface_NN
        (_( V_NNP 80_CD E_NNP )_) could_MD bind_NN with_IN high_JJ affinity_NN (_( K_NNP 
        d_SYM =_SYM 2_CD nM_NN )_) to_TO a_DT protein_NN with_IN a_DT mutation_NN
        in_IN the_DT ML_NNP surface_NN (_( A_DT 61_CD D_NNP )_) to_TO form_VB a_DT heterodimer_NN with_IN a_DT
        native_JJ interface_NN ._. In_IN addition_NN ,_, the_DT wild-type_JJ protein_NN forms_VBZ
        fibers_NNS ,_, visible_JJ by_IN electron_NN microscopy_NN ,_, that_WDT have_VBP a_DT similar_JJ
        width_NN to_TO the_DT V_NNP 80_CD E_NNP mutant_JJ polymer_NN we_PRP observed_VBD in_IN the_DT
        crystal_NN ._.
        While_IN the_DT wild-type_JJ and_CC V_NNP 80_CD E_NNP mutant_JJ SAM_NNP domains_NNS form_VBP
        fibers_NNS that_WDT are_VBP grossly_RB similar_JJ ,_, we_PRP cannot_NN be_VB certain_JJ that_IN
        the_DT mutation_NN does_VBZ not_RB significantly_RB alter_VB the_DT interface_NN ._.
        Even_RB a_DT small_JJ change_NN in_IN subunit_NN orientation_NN could_MD result_VB in_IN
        substantial_JJ alteration_NN of_IN the_DT structure_NN of_IN the_DT polymer_NN ,_,
        when_WRB propagated_JJ over_IN many_JJ subunits_NNS ._. We_PRP have_VBP therefore_RB
        determined_VBN the_DT structure_NN of_IN a_DT heterodimer_NN with_IN a_DT native_JJ
        interface_NN ._.
      
      
        Results_NNS and_CC Discussion_NNP
        
          Crystal_NNP structure_NN of_IN the_DT TEL-SAM_NNP dimer_NN
          We_PRP first_RB attempted_VBD to_TO grow_VB crystals_NNS of_IN the_DT V_NNP 80_CD E_NNP /_NN A_DT 61_CD D_NNP
          heterodimer_NN characterized_VBN previously_RB [_NN 7_CD ]_NN ,_, but_CC only_RB
          obtained_VBN crystals_NNS of_IN low_JJ quality_NN ._. We_PRP therefore_RB attempted_VBD
          to_TO crystallize_NN other_JJ variants_NNS and_CC were_VBD able_JJ to_TO obtain_VB
          high_JJ quality_NN crystals_NNS of_IN a_DT V_NNP 80_CD R_NN /_NN A_DT 61_CD D_NNP heterodimer_NN ._. The_DT
          protein_NN complex_JJ crystallized_JJ in_IN space_NN group_NN P_NN 1_CD with_IN cell_NN
          dimensions_NNS a_DT =_SYM 52_CD ._. 8_CD b_SYM =_SYM 60_CD ._. 3_LS c_SYM =_SYM 62_CD ._. 3_LS α_NN =_SYM 116_CD ._. 2_LS β_NN =_SYM 98_CD ._. 9_CD γ_NN =_SYM
          98_CD ._. 7_CD ._. There_EX were_VBD three_CD dimers_NNS in_IN the_DT asymmetric_JJ unit_NN ._. The_DT
          structure_NN was_VBD solved_VBN by_IN molecular_JJ replacement_NN using_VBG AMORE_NNP
          [_NN 20_CD ]_NN and_CC refined_VBN to_TO an_DT R_NN 
          free_JJ =_SYM 27_CD ._. 2_LS at_IN 2_CD ._. 3_CD Å_NN resolution_NN ._.
          Details_NNS of_IN the_DT structure_NN determination_NN and_CC refinement_NN are_VBP
          given_VBN in_IN Table_NNP I_PRP ._.
          The_DT structures_NNS of_IN the_DT three_CD heterodimers_NNS in_IN the_DT
          crystal_NN are_VBP essentially_RB identical_JJ ,_, with_IN an_DT average_JJ RMSD_NNP
          of_IN 0_CD ._. 68_CD Å_NN on_IN all_DT atoms_NNS ._. A_DT representative_NN heterodimer_NN is_VBZ
          shown_VBN in_IN Fig_NNP ._. 1_LS A_DT ._. As_IN shown_VBN in_IN Fig_NNP ._. 1_LS B_NNP ,_, the_DT interface_NN of_IN
          the_DT dimers_NNS consists_VBZ of_IN an_DT apolar_NN core_NN comprised_VBN of_IN Met_NNP 57_CD ,_,
          Ala_NNP 61_CD ,_, Leu_NNP 64_CD ,_, and_CC Leu_NNP 65_CD on_IN the_DT ML_NNP surface_NN and_CC Phe_NNP 45_CD ,_,
          Leu_NNP 47_CD ,_, Val_NNP 80_CD and_CC Leu_NNP 84_CD on_IN the_DT EH_NNP surface_NN ._. The_DT same_JJ
          residue_NN positions_NNS make_VBP up_RP the_DT core_NN of_IN the_DT V_NNP 80_CD E_NNP mutant_JJ
          structure_NN [_NN 7_CD ]_NN ._.
          As_IN in_IN the_DT V_NNP 80_CD E_NNP structure_NN ,_, a_DT network_NN of_IN salt-bridges_JJ
          surrounds_NNS the_DT apolar_NN core_NN ._. The_DT specific_JJ interactions_NNS in_IN
          the_DT salt-bridge_JJ network_NN are_VBP somewhat_RB variable_JJ and_CC differ_VB
          slightly_RB from_IN the_DT V_NNP 80_CD E_NNP structure_NN ._. In_IN the_DT structure_NN of_IN the_DT
          native_JJ interface_NN dimer_NN reported_VBD here_RB ,_, all_DT three_CD dimers_NNS in_IN
          the_DT asymmetric_JJ unit_NN contain_VB salt-bridges_JJ from_IN Glu_NNP 44_CD to_TO
          Lys_NNP 60_CD ,_, Arg_NNP 73_CD to_TO Asp_NNP 79_CD ,_, Asp_NNP 69_CD to_TO Arg_NNP 71_CD ,_, Glu_NNP 68_CD to_TO Lys_NNP 67_CD ,_,
          and_CC Asp_NNP 69_CD to_TO Lys_NNP 67_CD ._. Salt-bridges_NNP from_IN Glu_NNP 56_CD to_TO Arg_NNP 48_CD and_CC
          Glu_NNP 68_CD to_TO Arg_NNP 71_CD were_VBD found_VBN in_IN two_CD of_IN the_DT three_CD native_JJ
          interface_NN dimers_NNS ._. All_DT these_DT salt-bridges_JJ were_VBD also_RB
          observed_VBN in_IN at_IN least_JJS two_CD out_IN of_IN the_DT three_CD molecules_NNS in_IN
          the_DT asymmetric_JJ unit_NN of_IN the_DT V_NNP 80_CD E_NNP structure_NN ,_, with_IN the_DT
          exception_NN of_IN Glu_NNP 68_CD to_TO Lys_NNP 67_CD ,_, which_WDT was_VBD surprisingly_RB
          completely_RB absent_JJ in_IN the_DT V_NNP 80_CD E_NNP structure_NN [_NN 7_CD ]_NN ._. Thus_RB ,_,
          while_IN the_DT interfaces_NNS are_VBP grossly_RB similar_JJ in_IN all_PDT the_DT
          structures_NNS ,_, the_DT salt-bridging_JJ interactions_NNS are_VBP malleable_JJ ,_,
          shifting_VBG to_TO accommodate_VB slight_JJ changes_NNS in_IN the_DT geometry_NN of_IN
          the_DT subunits_NNS ._.
        
        
          Construction_NNP of_IN native_JJ polymer_NN model_NN
          Although_IN it_PRP is_VBZ not_RB possible_JJ to_TO obtain_VB a_DT
          high-resolution_JJ structure_NN of_IN the_DT wild-type_JJ polymer_NN
          experimentally_RB ,_, we_PRP can_MD construct_VB a_DT model_NN of_IN the_DT wild-type_JJ
          polymer_NN by_IN stringing_VBG together_RB repeated_VBN copies_NNS of_IN the_DT
          heterodimer_NN structure_NN ._. This_DT assumes_VBZ that_IN the_DT structural_JJ
          relationship_NN between_IN subunits_NNS is_VBZ not_RB very_RB flexible_JJ ._. The_DT
          rigidity_NN of_IN the_DT interface_NN is_VBZ borne_VBN out_IN by_IN the_DT fact_NN that_IN
          the_DT structure_NN of_IN three_CD dimers_NNS in_IN the_DT asymmetric_JJ unit_NN and_CC
          the_DT structure_NN of_IN the_DT mutant_JJ V_NNP 80_CD E_NNP (_( see_VB below_IN )_) are_VBP so_RB
          similar_JJ ._. The_DT procedure_NN for_IN constructing_VBG a_DT wild-type_JJ
          polymer_NN model_NN is_VBZ shown_VBN schematically_RB in_IN figure_NN 2_CD A_DT ._.
          Starting_VBG with_IN a_DT single_JJ subunit_NN ,_, additional_JJ subunits_NNS were_VBD
          added_VBN by_IN aligning_VBG a_DT subunit_NN of_IN the_DT heterodimer_NN to_TO the_DT
          last_JJ subunit_NN of_IN the_DT existing_VBG polymer_NN chain_NN ._. The_DT new_JJ
          subunit_NN was_VBD then_RB added_VBN to_TO the_DT existing_VBG chain_NN ._. This_DT
          procedure_NN was_VBD used_VBN to_TO construct_VB three_CD different_JJ polymers_NNS
          using_VBG the_DT three_CD dimers_NNS in_IN the_DT crystal_NN asymmetric_JJ unit_NN ._.
          The_DT resulting_VBG polymers_NNS were_VBD essentially_RB identical_JJ with_IN an_DT
          RMSD_NNP on_IN polymers_NNS of_IN nine_CD subunits_NNS of_IN 0_CD ._. 87_CD Å_NN on_IN backbone_NN
          atoms_NNS ._. The_DT architecture_NN of_IN one_CD of_IN the_DT resulting_VBG polymer_NN
          structures_NNS is_VBZ shown_VBN in_IN Fig_NNP ._. 2_LS B_NNP ._.
        
        
          The_DT wild-type_JJ polymer_NN is_VBZ similar_JJ to_TO its_PRP$ mutant_JJ
          counterpart_NN
          The_DT wild-type_JJ and_CC V_NNP 80_CD E_NNP mutant_JJ polymers_NNS are_VBP also_RB very_RB
          similar_JJ as_IN shown_VBN in_IN Figure_NN 2_CD B_NNP ._. Both_DT polymers_NNS contain_VBP SAM_NNP
          subunits_NNS arranged_VBD as_IN a_DT left-handed_JJ helix_NN with_IN a_DT 6_CD 
          5_CD screw_NN symmetry_NN ._. The_DT repeat_NN distance_NN
          of_IN the_DT polymers_NNS is_VBZ essentially_RB identical_JJ ,_, differing_VBG by_IN
          only_RB one_CD angstrom_NN (_( 53_CD Å_NN for_IN mutant_JJ and_CC 52_CD Å_NN for_IN
          wild-type_JJ )_) ._. These_DT results_NNS confirm_VBP the_DT architecture_NN of_IN the_DT
          wild-type_JJ polymer_NN proposed_VBN previously_RB based_VBN on_IN the_DT V_NNP 80_CD E_NNP
          mutant_JJ structure_NN ._.
        
        
          SAM_NNP interface_NN as_IN possible_JJ drug_NN target_NN
          SAM_NNP domain_NN oligomerization_NN is_VBZ the_DT key_JJ event_NN that_WDT
          triggers_VBZ a_DT variety_NN of_IN leukemias_NNS [_NN 21_CD ]_NN and_CC is_VBZ therefore_RB
          an_DT attractive_JJ target_NN for_IN therapeutic_JJ intervention_NN ._.
          Compounds_NNP that_WDT inhibit_VBP SAM_NNP association_NN could_MD be_VB effective_JJ
          in_IN preventing_VBG activation_NN of_IN the_DT aberrant_NN SAM_NNP /_NN tyrosine_NN
          kinase_NN fusions_NNS and_CC consequent_JJ cell_NN transformation_NN ._. Deep_JJ
          pockets_NNS on_IN a_DT protein_NN surface_NN make_NN ideal_JJ sites_NNS for_IN the_DT
          binding_JJ of_IN small_JJ molecule_NN inhibitors_NNS because_IN the_DT surface_NN
          area_NN available_JJ for_IN binding_JJ can_MD be_VB maximized_JJ [_NN 22_CD ]_NN ._.
          Figure_NN 3_CD shows_VBZ the_DT interacting_VBG surfaces_VBZ of_IN the_DT SAM_NNP domain_NN
          in_IN the_DT polymer_NN ._. There_EX are_VBP no_DT obvious_JJ deep_JJ pockets_NNS for_IN
          design_NN of_IN small_JJ molecule_NN inhibitors_NNS ._.
        
      
      
        Conclusion_NNP
        In_IN this_DT report_NN we_PRP have_VBP extracted_VBN a_DT TEL-SAM_NNP dimer_NN from_IN
        the_DT wild-type_JJ polymer_NN and_CC present_JJ its_PRP$ crystal_NN structure_NN ._.
        The_DT native_JJ interface_NN was_VBD found_VBN to_TO be_VB similar_JJ to_TO the_DT
        previously_RB solved_VBN mutant_JJ interface_NN ._. We_PRP also_RB constructed_VBN a_DT
        model_NN of_IN the_DT native_JJ polymer_NN and_CC found_VBD it_PRP to_TO be_VB similar_JJ to_TO
        the_DT previously_RB proposed_VBN mutant_JJ polymer_NN ._. Thus_RB ,_, the_DT polymer_NN
        architecture_NN is_VBZ sufficiently_RB robust_JJ to_TO withstand_VB a_DT mutation_NN
        from_IN a_DT hydrophobic_JJ to_TO a_DT charged_VBN residue_NN in_IN the_DT center_NN of_IN
        the_DT subunit_NN interface_NN ._. We_PRP have_VBP recently_RB determined_VBN the_DT
        polymer_NN structure_NN of_IN the_DT SAM_NNP domain_NN from_IN another_DT protein_NN
        involved_VBN in_IN transcriptional_NN repression_NN ,_, the_DT polycomb_NN group_NN
        protein_NN polyhomeotic_JJ (_( Ph_NNP )_) [_NN Kim_NNP et_CC al_NN ._. ,_, in_IN press_NN ]_NN ._. The_DT
        Ph-_NNP SAM_NNP polymer_NN is_VBZ quite_RB similar_JJ to_TO the_DT TEL-SAM_NNP polymer_NN even_RB
        though_IN the_DT proteins_NNS have_VBP an_DT unrelated_JJ domain_NN structure_NN and_CC
        show_NN less_JJR than_IN 20_CD %_NN sequence_NN identity_NN between_IN the_DT SAM_NNP
        domains_NNS ._. Moreover_RB ,_, different_JJ residues_NNS are_VBP involved_VBN in_IN the_DT
        inter-subunit_JJ interactions_NNS ._. We_PRP therefore_RB speculate_VBP that_IN the_DT
        polymer_NN architecture_NN is_VBZ conserved_JJ for_IN an_DT important_JJ role_NN in_IN
        transcriptional_NN repression_NN ,_, possibly_RB involving_VBG in_IN the_DT
        generation_NN of_IN a_DT repressed_JJ chromatin_NN structure_NN [_NN 7_CD ]_NN ._. A_DT
        rigid_JJ ,_, well-defined_JJ polymer_NN structure_NN may_MD be_VB important_JJ for_IN
        organizing_VBG chromatin_NN in_IN this_DT manner_NN ._.
        From_IN the_DT structure_NN ,_, we_PRP found_VBD that_IN the_DT interacting_VBG
        surfaces_VBZ of_IN the_DT SAM_NNP domains_NNS are_VBP devoid_JJ of_IN the_DT deep_JJ pockets_NNS
        that_WDT are_VBP ideal_JJ for_IN small_JJ molecule_NN binding_JJ ._. Although_IN it_PRP may_MD
        still_RB be_VB possible_JJ to_TO find_VB small_JJ molecule_NN inhibitors_NNS ,_, these_DT
        results_NNS are_VBP not_RB encouraging_VBG ._. Perhaps_RB a_DT more_RBR effective_JJ
        strategy_NN would_MD be_VB to_TO develop_VB protein_NN inhibitors_NNS ,_, such_JJ as_IN
        the_DT mutant_JJ SAM_NNP domains_NNS described_VBD here_RB ,_, that_WDT can_MD bind_NN with_IN
        high_JJ affinity_NN and_CC block_VB polymerization_NN ._. This_DT strategy_NN is_VBZ
        currently_RB being_VBG tested_VBN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Protein_NNP expression_NN ,_, mutagenesis_NNS and_CC
          purification_NN
          We_PRP used_VBD the_DT Quickchange_NNP kit_NN (_( Stratagene_NNP )_) to_TO generate_VB
          site_NN directed_VBD mutants_NNS ,_, V_NNP 80_CD R_NN and_CC A_DT 61_CD D_NNP from_IN wild-type_JJ
          TEL-SAM_NNP cloned_VBN into_IN a_DT modified_VBN pET_NN 3_CD c_SYM vector_NN (_( Novagen_NNP )_) [_NN 7_CD
          ]_NN ._. The_DT expressed_VBN protein_NN sequence_NN includes_VBZ an_DT MEKTR_NNP
          leader_NN sequence_NN ,_, followed_VBN by_IN residues_NNS 38_CD -_: 124_CD of_IN the_DT TEL_NNP
          protein_NN and_CC then_RB a_DT C-_NNP terminal_NN His_PRP$ tag_NN ._. Recombinant_NNP V_NNP 80_CD R_NN
          and_CC A_DT 61_CD D_NNP mutants_NNS were_VBD expressed_VBN in_IN E_NNP ._. Coli_NNP BL_NNP 21_CD (_( DE_NNP 3_LS )_)
          pLysS_NN cells_NNS (_( Novagen_NNP )_) ,_, and_CC purified_JJ by_IN Ni-_NNP NTA_NNP (_( Qiagen_NNP )_)
          and_CC HiTrap_NNP SP_NNP (_( Pharmacia_NNP )_) affinity_NN column_NN chromatography_NN
          followed_VBN by_IN ammonium_NN sulfate_NN precipitation_NN as_IN described_VBN
          by_IN Kim_NNP et_CC al_NN [_NN 7_CD ]_NN ._.
        
        
          Crystallization_NNP ,_, data_NNS collection_NN and_CC
          refinement_NN
          To_TO generate_VB the_DT native_JJ dimer_NN ,_, equal_JJ amounts_NNS of_IN each_DT
          mutant_JJ dimer_NN (_( both_DT at_IN 15_CD mg_NN /_NN ml_NN )_) were_VBD mixed_JJ together_RB prior_RB
          to_TO crystallization_NN ._. Crystals_NNP were_VBD grown_VBN by_IN the_DT hanging_VBG
          drop_NN method_NN in_IN which_WDT 2_CD μl_NN of_IN the_DT 7_CD ._. 5_CD mg_NN /_NN ml_NN dimer_NN solution_NN
          in_IN 10_CD mM_NN bis_NNS tris_NNS propane_NN (_( pH_NN 8_CD ._. 5_LS )_) and_CC 200_CD mM_NN NaCl_NNP ,_, were_VBD
          mixed_VBN with_IN 2_CD μl_NN of_IN reservoir_NN solution_NN containing_VBG 5_CD %_NN PEG_NNP
          4000_CD and_CC 2_CD ._. 0_CD M_NNP ammonium_NN sulfate_NN ._. Hexagonal_NNP rod-like_JJ
          crystals_NNS grew_VBD at_IN room_NN temperature_NN over_IN a_DT six-week_JJ period_NN ._.
          Crystals_NNP were_VBD cryo-protected_JJ with_IN the_DT reservoir_NN solution_NN
          enriched_JJ with_IN 30_CD %_NN (_( w_NN /_NN v_NN )_) glycerol_NN before_IN data_NNS collection_NN
          under_IN a_DT liquid_JJ nitrogen_NN stream_NN ._. The_DT data_NNS was_VBD processed_VBN
          with_IN DENZO_NNP /_NN SCALEPACK_NNP [_NN 23_CD ]_NN ._. The_DT molecular_JJ replacement_NN
          solution_NN was_VBD found_VBN using_VBG AMORE_NNP [_NN 20_CD ]_NN with_IN a_DT previously_RB
          solved_VBN TEL-SAM_NNP mutant_JJ (_( V_NNP 80_CD E_NNP )_) dimer_NN structure_NN as_IN the_DT
          search_NN model_NN ._. The_DT program_NN O_NNP [_NN 24_CD ]_NN was_VBD used_VBN for_IN model_NN
          building_NN and_CC CNS_NNP [_NN 25_CD ]_NN was_VBD used_VBN for_IN refinement_NN ._. Water_NNP
          molecules_NNS and_CC sulfates_NNS were_VBD added_VBN to_TO the_DT model_NN near_IN the_DT
          end_NN of_IN refinement_NN using_VBG difference_NN electron_NN density_NN maps_NNS ._.
          The_DT final_JJ model_NN has_VBZ a_DT crystallographic_JJ R-_NNP factor_NN (_( Rcryst_NNP )_)
          of_IN 23_CD ._. 0_CD %_NN and_CC R-_NNP free_JJ of_IN 27_CD ._. 2_LS %_NN on_IN 10_CD %_NN of_IN the_DT data_NNS (_( Table_NNP
          1_LS )_) ._. The_DT program_NN O_NNP was_VBD also_RB used_VBN for_IN subsequent_JJ
          construction_NN of_IN the_DT native_JJ polymer_NN ._.
        
        
          Coordinates_NNP
          Coordinates_NNP have_VBP been_VBN deposited_VBN in_IN the_DT Protein_NNP Data_NNP
          Bank_NNP (_( Accession_NNP Code_NNP 1_CD LKY_NNP )_) ._.
        
      
    
  
